A Phase I/II Trial of the Potent Hsp90 Inhibitor STA-9090 Administered Once Weekly In Patients with Advanced Hematologic Malignancies

作者:Lancet Jeffrey E; Smith B Douglas; Bradley Robert; Komrokji Rami S; Teofilovici Florentina; Rizzieri David A
来源:52nd Annual Meeting of the American-Society-of-Hematology (ASH), 2010-12-04 to 2010-12-07.
  • 出版日期2010-11-19